Clinical research highlights
The Stanford Thoracic Cancer team is engaged in cutting-edge research and offers a wide number and variety of clinical trials incorporating novel treatments for both early and advanced-stage lung cancers, including:
- Combination trials with surgery, radiation and drug therapy
- Immune therapy (cancer vaccine) as an adjuvant to surgery
- Dendritic cell vaccines and autologous tumor cell vaccines
- New combinations of oral agents that counteract resistance to targeted therapies
- Advanced imaging, motion control and delivery of radiation therapy
- Stereotactic radiotherapy and targeted inhibitors for lung cancer metastases to the brain
- Molecular analysis of lung and thymic tumors
Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.
Clinical trial eligibility flowcharts
Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all thoracic and lung cancer eligibility flowcharts at the Stanford Cancer Institute.